Achondroplasia: Diagnosis, Treatment, New Therapies, and Limb Lengthening
What Is Achondroplasia?
Achondroplasia is the most common form of disproportionate dwarfism and is a rare genetic disorder affecting bone development. Individuals with achondroplasia typically have a normal-sized trunk, while the upper and lower limbs are shorter due to reduced growth at the growth plates.
Achondroplasia affects approximately 1 in every 20,000–30,000 live births and occurs equally in males and females worldwide. In most cases, it is caused by a mutation of the FGFR3 (Fibroblast Growth Factor Receptor 3) gene, which leads to excessive receptor activity and limits the normal growth of long bones.
The condition follows an autosomal dominant inheritance pattern, meaning that an affected parent has a 50% chance of passing the mutation on to their child. However, approximately 80% of cases result from a de novo mutation, meaning the genetic change occurs spontaneously in children born to parents of average stature.
Today, thanks to advances in medicine, multidisciplinary care, new pharmacological therapies, and modern reconstructive surgical techniques, life expectancy is generally comparable to that of the general population, provided that potential complications are recognized and treated early.
In recent years, the treatment of achondroplasia has changed dramatically. The introduction of new pharmacological therapies has opened opportunities that would have been unimaginable only a few years ago. However, in patients who are candidates for limb lengthening, reconstructive surgery continues to play a fundamental role and should now be carefully integrated with medical therapy to achieve the best possible functional and height outcomes.
What Problems Can Achondroplasia Cause?
Achondroplasia is not limited to short stature. It is a genetic condition that can affect multiple organs and body systems, with varying degrees of severity from one individual to another. Some patients experience only mild manifestations, whereas others may develop orthopedic, neurological, or respiratory complications requiring specialist follow-up throughout childhood and, in some cases, adulthood.
From a skeletal standpoint, the hallmark feature is the presence of shortened limbs compared with the trunk, caused by reduced growth of the long bones. This may be associated with lower limb deformities such as genu varum (bow legs), knee instability, and alignment abnormalities that can affect walking and increase the risk of early joint degeneration.
The hands also have characteristic features, including short, broad fingers and increased separation between the third and fourth fingers, commonly referred to as the “trident hand”.
Achondroplasia may also be associated with ligamentous laxity, making some joints more flexible than normal, while others, such as the elbows, may have reduced range of motion. These abnormalities contribute to the functional limitations experienced by some patients in everyday life.
Among the most important complications are neurological disorders. During early childhood, foramen magnum stenosis, a narrowing of the opening at the base of the skull through which the spinal cord passes, may occur. This condition requires careful monitoring because, in severe cases, neurosurgical treatment may be necessary. Later in life, lumbar spinal stenosis may develop, causing pain, walking difficulties, numbness, tingling, or reduced walking endurance.
Anatomical differences involving the facial skeleton and upper airways may predispose patients to recurrent ear infections, hearing impairment, snoring, and sleep-disordered breathing, including obstructive sleep apnea, all of which require specialist evaluation.
Overall, these characteristics may lead to varying degrees of functional limitation. Some individuals lead an almost normal life, while others experience difficulties with daily activities, sports, or certain occupations. For this reason, achondroplasia requires a personalized, multidisciplinary approach aimed at preventing complications, improving function, and ensuring the best possible quality of life.
Management Should Be Multidisciplinary
Achondroplasia is a complex condition that may affect multiple organs and body systems. For this reason, treatment should not rely on a single specialist but instead requires the involvement of a multidisciplinary team capable of following the patient from diagnosis through adulthood.
Each stage of growth presents different challenges, and the treatment plan should be individualized, with regular follow-up and close collaboration among the various healthcare professionals involved.
The specialists who may be involved include:
- Geneticist, who confirms the diagnosis, provides genetic counseling to the family, and keeps them informed about the latest therapeutic options.
- Pediatrician, who coordinates the monitoring of the child’s growth and overall development.
- Neurosurgeon, who evaluates and treats foramen magnum stenosis or spinal canal stenosis when necessary.
- Orthopedic Surgeon, who monitors the development of limb deformities, evaluates the need for surgery, and plans corrective procedures or limb lengthening. This specialist should become involved as early as possible to properly plan each intervention at the most appropriate stage of growth, maximizing function while minimizing the physical and psychological burden on the patient.
- Physical Therapist, who plays a key role in improving mobility, muscle strength, balance, and postoperative recovery.
- Otolaryngologist (ENT Specialist), who manages recurrent ear infections, hearing disorders, and upper airway problems.
- Pulmonologist or Sleep Medicine Specialist, for patients with snoring, obstructive sleep apnea, or other respiratory disorders.
- Psychologist, when appropriate, to support both the patient and the family throughout the different stages of growth, helping them cope with the emotional, social, and psychological challenges associated with the condition.
In recent years, the introduction of new pharmacological therapies and the continuous advancement of reconstructive surgical techniques have made shared treatment planning among specialists more important than ever. The decision regarding the optimal time to initiate medical therapy, correct a deformity, or perform limb lengthening should result from a multidisciplinary evaluation aimed at achieving the best possible functional outcome and long-term quality of life.
The Role of Patient Associations
Receiving a diagnosis of achondroplasia can be an overwhelming experience, especially for parents of a newborn child. Beyond the medical aspects, families often face many questions regarding growth, development, school, sports, independence, and future expectations.
Throughout this journey, patient associations play a fundamental role. They provide an important source of support for families, encouraging connections with others facing similar experiences while offering reliable, up-to-date information based on the latest scientific evidence.
Patient associations also contribute by:
- providing support to families from the moment of diagnosis;
- promoting accurate information about achondroplasia and combating misconceptions and prejudice;
- organizing educational meetings, conferences, and opportunities for patients, families, and healthcare professionals to share experiences;
- supporting scientific research and facilitating access to new therapies;
- raising public awareness and advocating for the needs and rights of individuals living with achondroplasia.
Connecting with other families who have already gone through this journey can be extremely valuable, both practically and emotionally. Sharing experiences, challenges, and achievements often helps families face each stage of growth with greater confidence and awareness.
Decisions regarding treatments, including new pharmacological therapies and limb lengthening procedures, can also be approached with greater confidence when discussed within a multidisciplinary team and supported by accurate information and open dialogue with patient associations.
How the Treatment of Achondroplasia Has Changed Over the Last 20 Years
Over the past two decades, the treatment of achondroplasia has undergone a profound transformation. In the past, therapeutic options were largely limited to managing orthopedic complications and, in selected cases, performing limb lengthening. Today, the approach has become far more comprehensive and personalized.
The evolution of surgical techniques has led from traditional external fixators to modern combined techniques and magnetic intramedullary lengthening nails, making treatment more precise, safer, and more comfortable for patients.
More recently, another major breakthrough has emerged: targeted pharmacological therapies, designed to act directly on the biological mechanisms responsible for achondroplasia and promote more physiological bone growth during childhood.
Today, treatment is no longer about choosing between medication or surgery. The modern approach integrates different therapeutic strategies into a personalized treatment plan tailored to the characteristics and needs of each individual patient.
The goal is not simply to increase height, but also to prevent and correct deformities, improve limb function, enhance independence, and provide the best possible quality of life.
My Philosophy
“True innovation is not simply the arrival of new drugs or new surgical techniques, but the ability to integrate them into a single, personalized treatment pathway.”
New Drugs for Achondroplasia: A Revolution in Treatment
In recent years, the treatment of achondroplasia has undergone one of the most significant advances in its history. For the first time, medications have been developed that act directly on the biological mechanisms responsible for the disorder, offering the possibility of improving bone growth during childhood.
Until a few years ago, the management of achondroplasia relied primarily on monitoring complications and, when necessary, surgically correcting deformities or performing limb lengthening. Today, pharmacological therapy represents a new opportunity for many children, although it does not replace the role of reconstructive surgery.
How Do These Drugs Work?
Achondroplasia is caused by a mutation in the FGFR3 gene, which results in excessive activity of a receptor involved in regulating bone growth. This overactivity slows the proliferation of cartilage cells within the growth plates, leading to reduced longitudinal growth of the long bones.
The new medications aim to counteract the excessive activity of the FGFR3 receptor, promoting bone growth that is closer to normal. Although they work through different mechanisms, their common goal is to improve skeletal development during the growing years.
What Are the Main Medications?
Currently, the best-known medication is vosoritide, which has been approved in several countries for the treatment of children with achondroplasia who still have open growth plates.
In addition to vosoritide, several other molecules are currently under clinical investigation or development, including:
- Infigratinib, which acts directly on the FGFR3 receptor;
- Recifercept, a recombinant protein designed to reduce FGFR3 receptor activity;
- other investigational therapies that may further expand treatment options in the coming years.
Research in this field is evolving rapidly, making the availability of additional therapeutic options increasingly likely in the near future.
Which Patients Can Benefit?
At present, these therapies are intended primarily for children whose growth plates are still open, since their effectiveness depends on active bone growth.
For this reason, an early evaluation by an experienced multidisciplinary team is essential in order to identify the optimal time to begin medical therapy and to plan the subsequent treatment pathway.
What Results Can These Treatments Achieve?
Clinical studies have shown that these medications can increase the growth velocity of children with achondroplasia and improve several aspects of skeletal development.
This represents an important breakthrough, as until only a few years ago no pharmacological therapy was capable of producing these effects.
However, the magnitude of the benefit varies among patients and depends on several factors, including the age at which treatment is started, the duration of therapy, and individual biological characteristics.
What Are the Limitations of These New Medications?
Although they represent a major advance, the new medications do not provide a definitive cure for achondroplasia.
At present, they cannot correct lower limb deformities, eliminate spinal canal or foramen magnum stenosis, or achieve—on their own—the height gains obtainable through carefully planned limb lengthening procedures. Limb lengthening therefore remains essential for correcting deformities, improving function and, in selected patients, achieving a height closer to that of the general population. Clinical studies have shown that these medications can increase annual growth velocity by approximately 1–1.5 cm per year compared with the natural growth rate of children with achondroplasia.
For these reasons, many patients will continue to require orthopedic or surgical treatment during childhood and adolescence.
Why Does Limb Lengthening Remain Fundamental?
The introduction of new medications has profoundly changed the way achondroplasia is treated, but it has not eliminated the role of reconstructive surgery.
Limb lengthening remains the only treatment capable of achieving substantial increases in height, often amounting to several tens of centimeters as part of a carefully planned treatment program carried out throughout growth. In addition, it allows simultaneous correction of lower limb deformities, limb length discrepancies, and other orthopedic problems that pharmacological therapy alone cannot address.
Today, the goal is no longer to choose between medication and surgery, but rather to integrate the available therapeutic options. The best strategy results from early planning shared by the family and an experienced multidisciplinary team, carefully determining the most appropriate time to begin medical therapy, correct deformities when necessary, and initiate a personalized limb lengthening program.
Why Limb Lengthening Remains a Key Treatment
The introduction of new medications represents one of the greatest advances in the history of achondroplasia treatment. For the first time, it has become possible to target directly the biological mechanisms responsible for abnormal bone growth, offering many children a therapeutic opportunity that did not exist only a few years ago.
This important progress, however, has not replaced reconstructive surgery; rather, it has changed how surgery is planned and integrated into the overall treatment pathway.
Today, limb lengthening remains the only treatment capable of achieving height gains far greater than those obtained with pharmacological therapy alone. In addition, it addresses orthopedic problems that medications cannot correct by themselves.
The goals of limb lengthening include:
- significantly increasing height;
- correcting lower limb deformities;
- treating limb length discrepancies;
- improving limb alignment;
- enhancing independence in daily activities;
- facilitating everyday tasks such as reaching objects, using standard furniture, and participating more easily in work, sports, and social activities.
For these reasons, pharmacological therapy and surgery should not be considered alternative treatments, but complementary tools. The treatment strategy should always be individualized, taking into account the patient’s age, remaining growth potential, existing deformities, functional goals, and the expectations of both the patient and the family.
In recent years, the therapeutic strategy has changed considerably. Whereas limb lengthening programs were once planned almost exclusively according to the child’s natural growth, they must now also take into account the effects of new pharmacological therapies. This makes early assessment by an experienced multidisciplinary team even more important, allowing medical and surgical treatments to be integrated over time.
Limb lengthening is not a single operation, but a carefully planned journey. Determining the optimal time to begin treatment, selecting which bone segments should be lengthened, and coordinating these decisions with pharmacological therapy help achieve better outcomes while reducing the risk of complications.
Today, the objective is no longer to choose between medication and surgery, but to build a personalized treatment program, in which each therapeutic option contributes—at the appropriate time—to improving quality of life, function, and independence.
Limb lengthening should not be viewed as an alternative to new pharmacological therapies, but as an integral part of a modern treatment pathway. True innovation lies in the appropriate integration of medical therapy and reconstructive surgery, carefully planning every stage of growth to achieve the best possible functional and height outcomes.
When Should Limb Lengthening Begin?
One of the questions most frequently asked by families is: what is the best age to begin limb lengthening?
The answer is less straightforward than it may seem. There is no single ideal age for every patient, because each child has different clinical characteristics, growth patterns, possible deformities, and treatment goals.
For example, the presence of a significant lower limb deformity may make earlier surgery appropriate. In these cases, the deformity may be corrected with guided-growth plates or, when necessary, with external fixators based on the Ilizarov technique or with lengthening intramedullary nails, while also taking the opportunity to begin the limb lengthening pathway.
For this reason, today it is more appropriate to speak of planning the entire treatment pathway rather than focusing only on the timing of a single operation. It is therefore essential for the child to be assessed early by a surgeon experienced in limb reconstruction and lengthening. Early specialist care makes it possible to plan future procedures, monitor the progression of deformities, assess growth potential, and correctly integrate new pharmacological therapies with surgical treatment.
Planning Should Begin Early
Even if the first limb lengthening procedure is usually performed only several years later, it is essential for the patient to be assessed early by a surgeon experienced in limb reconstruction and lengthening.
The purpose of the first consultation is not to set a date for surgery, but to develop a personalized treatment pathway, following the child throughout growth and progressively adapting the plan to their clinical needs.
During follow-up, several factors are assessed, including:
- the child’s growth and remaining growth potential;
- the progression of lower limb deformities;
- the possible development of limb length discrepancies;
- joint function and bone quality;
- the response to any pharmacological treatment;
- the patient’s psychological development and level of maturity;
- the goals and expectations of both the child and the family.
All this information makes it possible to define a dynamic treatment program that can be modified over time according to clinical progression, growth, and advances in scientific research. Careful planning allows the most appropriate timing to be selected for each treatment, integrating pharmacological therapy, deformity correction, and limb lengthening when necessary, with the aim of achieving the best possible functional and height outcome.
How New Medications Have Changed the Strategy
The introduction of new pharmacological therapies has profoundly changed the way achondroplasia treatment is planned.
In the past, surgery was the only option capable of achieving a significant increase in height. Today, treatment planning must also take into account the benefits offered by new medications. Although their effect on growth is considerably more limited than that achieved through limb lengthening, their use in combination with surgery may help optimize the final outcome.
For this reason, limb lengthening planning must consider several factors:
- the age at which pharmacological therapy is started;
- the individual’s response to treatment;
- the growth achieved over time;
- the possible development of deformities;
- the patient’s functional and height-related goals.
The treatment strategy therefore becomes even more individualized.
Medication and Surgery Should Be Planned Together
Modern achondroplasia treatment is not based on choosing between medication and limb lengthening.
On the contrary, the two options should be considered from the outset as parts of a single treatment pathway, defined by a multidisciplinary team together with the patient and their family.
Appropriate planning makes it possible to identify the best time to begin each treatment, optimize outcomes, and reduce the risk of complications.
A Pathway That Lasts Several Years
Limb lengthening should not be viewed as a single operation, but as a treatment pathway that may extend over several years, accompanying the child throughout growth.
In some patients, a single procedure may be sufficient, whereas others may require several operations involving different skeletal segments at different stages. Every decision is made with respect for the biological safety of the tissues, the patient’s remaining growth potential, and their functional and height-related goals.
For this reason, treatment should be managed by a surgeon with specific expertise in limb reconstruction and lengthening, working within a multidisciplinary team. Only careful planning and continuous follow-up make it possible to adapt the treatment program to the child’s clinical development, integrating deformity correction, limb lengthening, and the most advanced pharmacological therapies when indicated.
My Treatment Philosophy
“In my clinical practice, I do not plan a single operation, but the patient’s entire growth pathway. From the first consultation, I consider age, remaining growth potential, possible pharmacological therapy, existing deformities, and functional goals. This makes it possible to develop a personalized program that accompanies the patient for several years and adapts to their clinical development.”
How to Plan a Limb Lengthening Program
One of the most complex aspects of achondroplasia treatment is not the individual operation, but the planning of the entire limb lengthening program.
Each patient has different characteristics, and there is no single protocol suitable for everyone. The number of procedures, the skeletal segments to be treated, the age at which treatment should begin, and the final goals are determined according to the child’s growth, any existing deformities, the response to pharmacological therapies, and the expectations of the patient and their family.
Which Skeletal Segments Can Be Lengthened?
Depending on the patient’s needs, lengthening procedures may involve:
- the femurs, to increase height and improve lower limb proportions;
- the tibias, to achieve additional height gain and correct any associated deformities;
- the humeri, in selected cases, to improve upper limb function and facilitate many activities of daily living.
How Many Procedures Are Required?
There is no predetermined number of procedures.
Some patients achieve their goals with one or two lengthening procedures, while others may benefit from a more extensive program involving several operations performed at different stages of growth. Each procedure is planned in accordance with the biological healing process, allowing the body sufficient time to recover fully before the next stage.
How Long Does the Treatment Pathway Take?
Limb lengthening is a treatment plan that may extend over several years.
Between one procedure and the next, time is required for bone consolidation, muscle recovery, physiotherapy, and a return to normal school, sports, and social activities. This careful planning helps reduce the risk of complications and allows each stage to be approached under the best possible conditions.
What Results Can Realistically Be Expected?
Treatment goals are defined together with the patient and their family and are always individualized. In our experience, it has been possible to achieve height gains of up to 46 cm, together, in selected cases, with the restoration of full upper limb function following humeral lengthening, enabling patients to carry out daily activities with a high degree of independence.
In addition to increasing height, the treatment program may improve limb alignment, correct deformities, increase independence in everyday activities, and make a significant contribution to quality of life.
The final result does not depend exclusively on the number of centimeters gained, but on achieving the right balance between safety, function, and the patient’s overall well-being.
Surgical Techniques for Limb Lengthening
Over the past forty years, limb lengthening techniques have undergone substantial development. Today, surgeons have several options available, each with specific indications based on the patient’s age, the presence of deformities, bone quality, lengthening goals, and the preferences of the patient and their family.
There is no single technique that is universally superior. Successful treatment depends on selecting the most appropriate method for each individual case.
Ilizarov External Fixator
The Ilizarov technique remains one of the cornerstones of limb reconstruction. A circular external fixator makes it possible to perform bone lengthening while simultaneously correcting even highly complex deformities.
It is an extremely versatile method, particularly suitable for pediatric patients, multiplanar deformities, and cases requiring simultaneous correction of limb alignment, rotation, and length. It also allows the correction to be progressively adjusted throughout treatment.
LON Technique: Lengthening Over Nail
The Lengthening Over Nail (LON) technique combines an external fixator with a conventional intramedullary nail.
Lengthening is initially performed using the external fixator, which is removed once the desired length has been achieved. Bone consolidation then continues with the support of the internal nail, significantly reducing the time spent wearing the external fixator and improving patient comfort.
This technique provides an effective balance between biological reliability and a shorter period of external fixator use.
LATN Technique: Lengthening and Then Nailing
With the Lengthening and Then Nailing (LATN) technique, the entire lengthening phase is completed using an external fixator. An intramedullary nail is then inserted to protect the bone during consolidation.
The aim is to increase the stability of the lengthened segment, allow earlier removal of the external fixator, and reduce the risk of fractures after fixator removal.
Magnetic Intramedullary Nails
Magnetic intramedullary nails represent one of the most important innovations in limb lengthening over the past decade.
Lengthening is achieved through a magnetic mechanism controlled externally, eliminating the need for an external fixator. This provides greater comfort, improves patient acceptance of the treatment, and reduces problems related to pins, wires, and superficial infections.
At present, these devices are used mainly in adolescents and adults with an adequate intramedullary canal and in the absence of deformities requiring complex correction.
Precice Max
The Precice Max represents the latest evolution of magnetic lengthening nails.
In addition to preserving the advantages of previous systems, it has been designed to allow much earlier weight-bearing, reducing one of the major limitations of traditional intramedullary lengthening nails. This may result in faster functional recovery and a better quality of life throughout treatment.
As this technology becomes more widely available, Precice Max is expected to become one of the reference systems for limb lengthening in carefully selected patients.
Which Technique Should Be Chosen?
The choice of technique depends not only on the device itself but, above all, on the characteristics of the individual patient.
Age, the presence of deformities, bone quality, the skeletal segment to be treated, the desired amount of lengthening, and the patient’s functional goals are all factors that must be carefully evaluated before surgery.
For this reason, the treatment of achondroplasia requires extensive experience in limb reconstruction and the ability to perform all the major limb lengthening techniques, selecting the most appropriate option for each individual patient.
Recovery
Recovery is a fundamental part of treatment. In addition to surgery, it requires physiotherapy, regular follow-up visits, and continuous monitoring until complete bone healing has occurred. The duration and recovery protocol vary according to the technique used, the patient’s age, and the amount of lengthening achieved.
Risks and Complications
Like any surgical procedure, limb lengthening carries potential risks and complications, including infection, joint stiffness, delayed bone healing, and muscle or tendon problems. In most cases, these can be prevented or successfully managed through careful planning, regular follow-up, and treatment by an experienced multidisciplinary team.
Expected Results
Results are individualized according to the patient’s characteristics and the goals established together with the family. In addition to increasing height, treatment can correct deformities, improve function, and enhance independence. In our experience, total height gains of up to 46 cm have been achieved through carefully planned treatment programs carried out over time. For the upper limbs, lengthening of 10–16 cm has been achieved, resulting in a marked improvement in independence, particularly with regard to personal hygiene and activities of daily living.
Clinical Cases
Frequently Asked Questions About Achondroplasia (FAQ)
What Is Achondroplasia?
Achondroplasia is the most common form of disproportionate dwarfism. It is caused by a mutation in the FGFR3 gene, which slows the growth of the long bones during development.
Is Achondroplasia Inherited?
Yes. It follows an autosomal dominant inheritance pattern, although approximately 80% of cases result from a new genetic mutation occurring in children born to parents of average stature.
How Is Achondroplasia Diagnosed?
Diagnosis is based on clinical examination and radiographic findings and can be confirmed by genetic testing to identify the FGFR3 mutation.
What Is the Life Expectancy of a Person with Achondroplasia?
In most cases, life expectancy is comparable to that of the general population, provided that any complications are diagnosed and treated promptly.
What Are the Main Orthopedic Problems?
The most common orthopedic complications include bow legs, lower limb deformities, spinal stenosis, joint instability, and functional limitations.
Can the New Medications Replace Limb Lengthening?
No. Medications can promote bone growth during childhood, but they do not correct deformities or replace surgery when surgical treatment is indicated.
When Should Limb Lengthening Be Started?
There is no single ideal age for every patient. The timing depends on growth, existing deformities, treatment goals, and the patient’s individualized treatment plan.
How Many Procedures Are Usually Required?
This depends on the treatment program. Some patients require only one procedure, while others benefit from several operations performed at different stages of growth.
Which Bones Can Be Lengthened?
The femurs, tibias, and humeri can all be lengthened to improve height and upper limb function.
How Many Centimeters Can Be Achieved?
The final result varies from patient to patient. In our experience, total height gains of up to 46 cm have been achieved through carefully planned limb lengthening programs carried out over time. For the upper limbs, 10–16 cm of lengthening has been achieved.
Is It Possible to Walk During Treatment?
Yes. In most cases, patients are able to remain ambulatory, although the degree of weight-bearing and walking depends on the technique used and the stage of treatment.
Is the Procedure Painful?
Pain is generally well controlled with medication and physiotherapy. Its intensity varies from patient to patient and usually decreases progressively throughout the treatment.
How Long Does Recovery Take?
Recovery depends on the technique used, the amount of lengthening achieved, and the patient’s individual biological response. Physiotherapy is essential throughout every stage of treatment.
What Are the Most Common Complications?
Potential complications include superficial infections, joint stiffness, delayed bone healing, muscle and tendon problems, and joint dislocations. In experienced hands, these complications can generally be prevented or successfully managed with appropriate treatment.
Is an External Fixator Better Than a Magnetic Nail?
There is no single technique that is universally superior. The choice depends on the patient’s age, the presence of deformities, bone quality, and the goals of treatment.
What Is the Ilizarov Technique?
The Ilizarov technique is a limb reconstruction method that uses a circular external fixator to gradually correct deformities while simultaneously lengthening the bone.
What Is Precice Max?
The Precice Max is a new-generation magnetic intramedullary lengthening nail designed to allow bone lengthening with earlier weight-bearing than previous models.
Can Deformities Be Corrected at the Same Time as Limb Lengthening?
Yes. In many cases, deformity correction and limb lengthening can be performed during the same procedure, reducing the total number of operations required.
How Should I Choose the Right Treatment Center?
It is advisable to choose a center with specific expertise in limb reconstruction and limb lengthening that can provide comprehensive care throughout the entire treatment journey.
